Recently, Gou et al. [43] demonstrated that plasma levels of TNF-α, IL-1β, and NLRP3 inflammasomes could be potentially used as risk factors for venous ulcers in patients with VVs of the lower extremity. This evidence concerns the gene IL1B and varicose ulcer.